other material
confidence high
sentiment neutral
materiality 0.50
Lucid Diagnostics shareholders approve increase in authorized shares, re-elect directors
Lucid Diagnostics Inc.
- Stockholders re-elected Dr. Lishan Aklog, Debra White, and Dennis Matheis as Class C directors.
- Approved amendment to increase authorized common stock from 200M to 300M shares.
- Approved issuance of shares under Series B and B-1 Convertible Preferred Stock for Nasdaq Listing Rule 5635.
- Ratified appointment of Marcum LLP as independent auditor for FY 2024.